查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1531001

达菲（磷酸奥司他韦）市场（药物类型：品牌药和仿製药；剂量：胶囊和混悬剂；适应症：甲型流感、乙型流感等）-全球产业分析、规模、份额、成长、趋势与预测， 2024-2034

Tamiflu (Oseltamivir Phosphate) Market (Drug Type: Branded, and Generic; Dosage: Capsule, and Suspension; and Indication: Influenza A, Influenza B, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 187 Pages | 商品交期: 2-10个工作天内

价格

达菲（磷酸奥司他韦）市场 - 报告范围

TMR 关于全球达菲（磷酸奥司他韦）市场的报告研究了过去以及当前的成长趋势和机会，以获得2024 年至2034 年预测期内市场指标的宝贵见解。收入（磷酸奥司他韦）市场2018-2034年，考虑2024年为基准年，2034年为预测年。报告中也提供了2024年至2034年全球达菲（磷酸奥司他韦）市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解达菲（磷酸奥司他韦）市场。

市场概况
2023年市场价值 19亿美元
2034 年市场价值 27亿美元
复合年增长率 3.3%

该报告深入研究了全球达菲（磷酸奥司他韦）市场的竞争格局。全球达菲（磷酸奥司他韦）市场的主要参与者已经确定，并对每位参与者的不同属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球达菲（磷酸奥司他韦）市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2020-2034 年全球市场分析与预测

第 5 章：关键见解

  • 全球流感流行状况
  • 波特五力分析
  • 重要产业活动
  • 监管场景

第 6 章：全球市场分析与预测：按药物类型

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年按药物类型分類的市场价值预测
    • 品牌化
    • 通用的
  • 按药物类型分類的市场吸引力

第 7 章：全球市场分析与预测：按剂量

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年按剂量分類的市场价值预测
    • 胶囊
    • 暂停
  • 按剂量分類的市场吸引力

第 8 章：全球市场分析与预测：依指标分类

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年市场价值预测（依指标）
    • 甲型流感
    • 乙型流感
    • 其他的
  • 按指标分類的市场吸引力

第 9 章：全球市场分析与预测：按配销通路

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年按配销通路分類的市场价值预测
    • 医院药房
    • 零售药局
    • 网路药局
    • 其他的
  • 按配销通路分類的市场吸引力

第 10 章：全球市场分析与预测：按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 按国家/地区分類的市场吸引力

第 11 章：北美市场分析与预测

  • 我们
  • 加拿大

第 12 章：欧洲市场分析与预测

  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区

第 13 章：亚太市场分析与预测

  • 中国
  • 印度
  • 日本
  • 澳洲和纽西兰
  • 亚太地区其他地区

第 14 章：拉丁美洲市场分析与预测

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区

第 15 章：中东和非洲市场分析与预测

  • 海湾合作委员会
  • 南非
  • 中东和非洲其他地区

第16章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 公司市占率分析 (2022)
  • 公司简介
    • F. Hoffmann-La Roche Ltd.
    • NATCO Pharma Limited
    • Teva Pharmaceutical Industries Ltd
    • LUPIN Limited
    • Amneal pharmaceuticals LLC
    • Zydus Cadila
    • Sun Pharmaceutical Industries Ltd.
    • Alembic Pharmaceuticals Limited
    • Mylan NV
    • Hetero Group
Product Code: TMRGL70965

Tamiflu (Oseltamivir Phosphate) Market - Scope of Report

TMR's report on the global tamiflu (oseltamivir phosphate) market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global tamiflu (oseltamivir phosphate) market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global tamiflu (oseltamivir phosphate) market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the tamiflu (oseltamivir phosphate) market.

Market Snapshot
Market Value in 2023US$ 1.9 Bn
Market Value in 2034US$ 2.7 Bn
CAGR3.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global tamiflu (oseltamivir phosphate) market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global tamiflu (oseltamivir phosphate) market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global tamiflu (oseltamivir phosphate) market.

The report delves into the competitive landscape of the global tamiflu (oseltamivir phosphate) market. Key players operating in the global tamiflu (oseltamivir phosphate) market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global tamiflu (oseltamivir phosphate) market profiled in this report.

Key Questions Answered in Global tamiflu (oseltamivir phosphate) Market Report:

  • What is the sales/revenue generated by tamiflu (oseltamivir phosphate) across all regions during the forecast period?
  • What are the opportunities in the global tamiflu (oseltamivir phosphate) market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Tamiflu (Oseltamivir Phosphate) Market - Research Objectives and Research Approach

The comprehensive report on the global tamiflu (oseltamivir phosphate) market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global tamiflu (oseltamivir phosphate) market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global tamiflu (oseltamivir phosphate) market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Tamiflu (Oseltamivir Phosphate) Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Drug Type Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecasts, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Influenza Flu Prevalence Globally
  • 5.2. Porter's Five Forces Analysis
  • 5.3. Key Industry Events
  • 5.4. Regulatory Scenario

6. Global Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecasts, By Drug Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Drug Type, 2020-2034
    • 6.3.1. Branded
    • 6.3.2. Generic
  • 6.4. Market Attractiveness By Drug Type

7. Global Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecasts, By Dosage

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Dosage, 2020-2034
    • 7.3.1. Capsule
    • 7.3.2. Suspension
  • 7.4. Market Attractiveness By Dosage

8. Global Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecasts, By Indication

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Indication, 2020-2034
    • 8.3.1. Influenza A
    • 8.3.2. Influenza B
    • 8.3.3. Others
  • 8.4. Market Attractiveness By Indication

9. Global Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecasts, By Distribution Channel

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By Distribution Channel, 2020-2034
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail Pharmacies
    • 9.3.3. Online Pharmacies
    • 9.3.4. Others
  • 9.4. Market Attractiveness By Distribution Channel

10. Global Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecasts, By Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast By Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Drug Type, 2020-2034
    • 11.2.1. Branded
    • 11.2.2. Generic
  • 11.3. Market Value Forecast By Dosage, 2020-2034
    • 11.3.1. Capsule
    • 11.3.2. Suspension
  • 11.4. Market Value Forecast By Indication, 2020-2034
    • 11.4.1. Influenza A
    • 11.4.2. Influenza B
    • 11.4.3. Others
  • 11.5. Market Value Forecast By Distribution Channel, 2020-2034
    • 11.5.1. Hospital Pharmacies
    • 11.5.2. Retail Pharmacies
    • 11.5.3. Online Pharmacies
    • 11.5.4. Others
  • 11.6. Market Value Forecast By Country, 2020-2034
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Drug Type
    • 11.7.2. By Dosage
    • 11.7.3. By Indication
    • 11.7.4. By Distribution Channel
    • 11.7.5. By Country

12. Europe Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Drug Type, 2020-2034
    • 12.2.1. Branded
    • 12.2.2. Generic
  • 12.3. Market Value Forecast By Dosage, 2020-2034
    • 12.3.1. Capsule
    • 12.3.2. Suspension
  • 12.4. Market Value Forecast By Indication, 2020-2034
    • 12.4.1. Influenza A
    • 12.4.2. Influenza B
    • 12.4.3. Others
  • 12.5. Market Value Forecast By Distribution Channel, 2020-2034
    • 12.5.1. Hospital Pharmacies
    • 12.5.2. Retail Pharmacies
    • 12.5.3. Online Pharmacies
    • 12.5.4. Others
  • 12.6. Market Value Forecast By Country, 2020-2034
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Drug Type
    • 12.7.2. By Dosage
    • 12.7.3. By Indication
    • 12.7.4. By Distribution Channel
    • 12.7.5. By Country

13. Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Drug Type, 2020-2034
    • 13.2.1. Branded
    • 13.2.2. Generic
  • 13.3. Market Value Forecast By Dosage, 2020-2034
    • 13.3.1. Capsule
    • 13.3.2. Suspension
  • 13.4. Market Value Forecast By Indication, 2020-2034
    • 13.4.1. Influenza A
    • 13.4.2. Influenza B
    • 13.4.3. Others
  • 13.5. Market Value Forecast By Distribution Channel, 2020-2034
    • 13.5.1. Hospital Pharmacies
    • 13.5.2. Retail Pharmacies
    • 13.5.3. Online Pharmacies
    • 13.5.4. Others
  • 13.6. Market Value Forecast By Country, 2020-2034
    • 13.6.1. China
    • 13.6.2. India
    • 13.6.3. Japan
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Drug Type
    • 13.7.2. By Dosage
    • 13.7.3. By Indication
    • 13.7.4. By Distribution Channel
    • 13.7.5. By Country

14. Latin America Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Drug Type, 2020-2034
    • 14.2.1. Branded
    • 14.2.2. Generic
  • 14.3. Market Value Forecast By Dosage, 2020-2034
    • 14.3.1. Capsule
    • 14.3.2. Suspension
  • 14.4. Market Value Forecast By Indication, 2020-2034
    • 14.4.1. Influenza A
    • 14.4.2. Influenza B
    • 14.4.3. Others
  • 14.5. Market Value Forecast By Distribution Channel, 2020-2034
    • 14.5.1. Hospital Pharmacies
    • 14.5.2. Retail Pharmacies
    • 14.5.3. Online Pharmacies
    • 14.5.4. Others
  • 14.6. Market Value Forecast By Country, 2020-2034
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Drug Type
    • 14.7.2. By Dosage
    • 14.7.3. By Indication
    • 14.7.4. By Distribution Channel
    • 14.7.5. By Country

15. Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Drug Type, 2020-2034
    • 15.2.1. Branded
    • 15.2.2. Generic
  • 15.3. Market Value Forecast By Dosage, 2020-2034
    • 15.3.1. Capsule
    • 15.3.2. Suspension
  • 15.4. Market Value Forecast By Indication, 2020-2034
    • 15.4.1. Influenza A
    • 15.4.2. Influenza B
    • 15.4.3. Others
  • 15.5. Market Value Forecast By Distribution Channel, 2020-2034
    • 15.5.1. Hospital Pharmacies
    • 15.5.2. Retail Pharmacies
    • 15.5.3. Online Pharmacies
    • 15.5.4. Others
  • 15.6. Market Value Forecast By Country, 2020-2034
    • 15.6.1. GCC
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Drug Type
    • 15.7.2. By Dosage
    • 15.7.3. By Indication
    • 15.7.4. By Distribution Channel
    • 15.7.5. By Country

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis By Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. F. Hoffmann-La Roche Ltd.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. NATCO Pharma Limited
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Teva Pharmaceutical Industries Ltd
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. LUPIN Limited
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Amneal pharmaceuticals LLC
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Zydus Cadila
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Sun Pharmaceutical Industries Ltd.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Alembic Pharmaceuticals Limited
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Mylan N.V.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Hetero Group
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 02: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Dosage Form, 2020-2034
  • Table 03: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 04: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 05: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 06: North America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 07: North America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 08: North America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Dosage Form, 2020-2034
  • Table 09: North America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 10: North America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 11: Europe Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 13: Europe Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Dosage Form, 2020-2034
  • Table 14: Europe Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 15: Europe Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 16: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 18: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Dosage Form, 2020-2034
  • Table 19: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 20: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 21: Latin America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 23: Latin America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Dosage Form, 2020-2034
  • Table 24: Latin America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 25: Latin America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 26: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 28: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Dosage Form, 2020-2034
  • Table 29: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 30: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034

List of Figures

  • Figure 01: Tamiflu (Oseltamivir Phosphate) Market Size, by Product, 2023
  • Figure 02: Tamiflu (Oseltamivir Phosphate) Market share (%), by Product, 2023
  • Figure 03: Tamiflu (Oseltamivir Phosphate) Market Size, by Dosage Form, 2023
  • Figure 04: Tamiflu (Oseltamivir Phosphate) Market Share (%), by Dosage Form, 2023
  • Figure 05: Tamiflu (Oseltamivir Phosphate) Market Size, by Application, 2023
  • Figure 06: Tamiflu (Oseltamivir Phosphate) Market share (%), by Application, 2023
  • Figure 07: Tamiflu (Oseltamivir Phosphate) Market Size, by Distribution Channel, 2023
  • Figure 08: Tamiflu (Oseltamivir Phosphate) Market share (%), by Distribution Channel, 2023
  • Figure 09: Global Tamiflu (Oseltamivir Phosphate) Market, By Region (2023 and 2034)
  • Figure 10: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 11: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Product, 2023 and 2034
  • Figure 12: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Product, 2023
  • Figure 13: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Product, 2034
  • Figure 14: Global Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Product, 2023-2034
  • Figure 15: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Branded, 2020-2034
  • Figure 16: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Branded, 2023 and 2034
  • Figure 17: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Generic, 2020-2034
  • Figure 18: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, Generic, 2023 and 2034
  • Figure 19: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Others , 2020-2034
  • Figure 20: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 21: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 22: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023
  • Figure 23: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2034
  • Figure 24: Global Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Dosage Form, 2023-2034
  • Figure 25: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Capsule, 2020-2034
  • Figure 26: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Capsule, 2023 and 2034
  • Figure 27: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Suspension, 2020-2034
  • Figure 28: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, Suspension, 2023 and 2034
  • Figure 29: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 30: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Application, 2023
  • Figure 31: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Application, 2034
  • Figure 32: Global Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 33: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Influenza A, 2020-2034
  • Figure 34: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Influenza A, 2023 and 2034
  • Figure 35: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Influenza B, 2020-2034
  • Figure 36: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, Influenza B, 2023 and 2034
  • Figure 37: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Others, 2020-2034
  • Figure 38: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Others, 2020-2034
  • Figure 39: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, Others, 2023 and 2034
  • Figure 40: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 41: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Distribution Channel, 2023
  • Figure 42: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Distribution Channel, 2034
  • Figure 43: Global Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Distribution Channel, 2023-2034
  • Figure 44: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Hospital Pharmacies, 2020-2034
  • Figure 45: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Hospital Pharmacies, 2023 and 2034
  • Figure 46: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Retail Pharmacies, 2020-2034
  • Figure 47: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, Retail Pharmacies, 2023 and 2034
  • Figure 48: Global Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn), by Others, 2020-2034
  • Figure 49: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 50: Global Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 51: Global Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 52: North America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 53: North America Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 54: North America Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Country, 2023-2034
  • Figure 55: North America Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Product, 2023 and 2034
  • Figure 56: North America Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Product, 2023-2034
  • Figure 57: North America Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 58: North America Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Dosage Form, 2023-2034
  • Figure 59: North America Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 60: North America Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Dosage Form, 2023-2034
  • Figure 61: North America Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 62: North America Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Distribution Channel, 2023-2034
  • Figure 63: Europe Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 64: Europe Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 65: Europe Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 66: Europe Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Product, 2023 and 2034
  • Figure 67: Europe Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Product, 2023-2034
  • Figure 68: Europe Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 69: Europe Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Dosage Form, 2023-2034
  • Figure 70: Europe Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 71: Europe Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 72: Europe Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 73: Europe Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Distribution Channel, 2023-2034
  • Figure 74: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 75: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 76: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 77: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Product, 2023 and 2034
  • Figure 78: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Product, 2023-2034
  • Figure 79: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 80: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Dosage Form, 2023-2034
  • Figure 81: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 82: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Dosage Form, 2023-2034
  • Figure 83: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 84: Asia Pacific Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Distribution Channel, 2023-2034
  • Figure 85: Latin America Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 86: Latin America Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 87: Latin America Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 88: Latin America Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Product, 2023 and 2034
  • Figure 89: Latin America Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Product, 2023-2034
  • Figure 90: Latin America Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 91: Latin America Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Dosage Form, 2023-2034
  • Figure 92: Latin America Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 93: Latin America Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Dosage Form, 2023-2034
  • Figure 94: Latin America Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 95: Latin America Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Distribution Channel, 2023-2034
  • Figure 96: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 97: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 98: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 99: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Product, 2023 and 2034
  • Figure 100: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Product, 2023-2034
  • Figure 101: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 102: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Dosage Form, 2023-2034
  • Figure 103: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 104: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Dosage Form, 2023-2034
  • Figure 105: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 106: Middle East & Africa Tamiflu (Oseltamivir Phosphate) Market Attractiveness Analysis, by Distribution Channel, 2023-2034